The Osteogenesis Imperfecta market size was valued ~USD 30 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034).

Osteogenesis Imperfecta Market Outlook and Forecast 2034

1. Key Insights
2. Report Introduction
3. Osteogenesis Imperfecta Market Overview at a Glance
3.1. Market Share (%) Distribution of Osteogenesis Imperfecta by Countries in 2023
3.2. Market Share (%) Distribution of Osteogenesis Imperfecta by Countries in 2034
4. Methodology
5. Executive Summary
6. Key Events
7. Disease Background and Overview
7.1. Introduction
7.2. Clinical Classification
7.3. Etiology
7.4. Signs and Symptoms
7.5. Pathophysiology
7.6. Inheritance Pattern
7.7.&nbsp;Osteogenesis Imperfecta Diagnosis
7.7.1. Differential diagnosis
7.7.2. Prenatal diagnosis
7.7.3. Diagnostic Guidelines
7.8. Treatment and Management of OI
7.8.1. Treatment Guidelines
8.&nbsp;Osteogenesis Imperfecta Epidemiology and Patient Population
8.1. Key Findings
8.2. Assumptions and Rationale: 7MM
8.3. Prevalent Cases of Osteogenesis Imperfecta in the 7MM
8.4. Diagnosed Cases of Osteogenesis Imperfecta in the 7MM
8.5. The United States
8.5.1. Prevalent Cases of Osteogenesis Imperfecta in the US
8.5.2. Diagnosed Cases of Osteogenesis Imperfecta in the US
8.5.3. Gene-specific Cases of Osteogenesis Imperfecta in the US
8.5.4. Type-specific Cases of Osteogenesis Imperfecta in the US
8.5.5. Total Treated Cases of Osteogenesis Imperfecta in the US
8.6. EU4 and the UK
8.6.1. Total Prevalent Cases of Osteogenesis Imperfecta
8.6.2. Total Diagnosed Cases of Osteogenesis Imperfecta
8.6.3. Gene-specific Cases of Osteogenesis Imperfecta
8.6.4. Type-specific Cases of Osteogenesis Imperfecta
8.6.5. Total Treated Cases of Osteogenesis Imperfecta
8.7. Japan
8.7.1. Total Prevalent Cases of Osteogenesis Imperfecta
8.7.2. Total Diagnosed Cases of Osteogenesis Imperfecta
8.7.3. Gene-specific Cases of Osteogenesis Imperfecta
8.7.4. Type-specific Cases of Osteogenesis Imperfecta
8.7.5. Total Treated Cases of Osteogenesis Imperfecta
9.&nbsp;Osteogenesis Imperfecta Patient Journey
10.&nbsp;Osteogenesis Imperfecta Emerging Therapies
10.1. Key Cross
10.2. EVENITY (romosozumab): Amgen/UCB
10.2.1. Product Description
10.2.2. Other Developmental Activities
10.2.3. Clinical Developmental Activities
10.2.4. Analyst View
10.3. Setrusumab (UX143): Ultragenyx Pharmaceuticals/Mereo BioPharma
10.3.1. Product Description
10.3.2. Other Developmental Activities
10.3.3. Clinical Developmental Activities
10.3.4. Safety and Efficacy
10.3.5. Analyst View
11. Market Analysis
11.1. Key Findings
11.2. Market Outlook
11.3. Conjoint Analysis
11.4. Key Market Forecast Assumptions
11.4.1. Cost Assumptions
11.4.2. Launch Year and Therapy Uptake
11.5. Total Market Size of Osteogenesis Imperfecta in the 7MM
11.6. United States Market Size
11.6.1. Total Market Size of Osteogenesis Imperfecta in the US (2020&ndash;2034)
11.6.2. Market Size of Osteogenesis Imperfecta by Therapies in the United States (2020-2034)
11.7. EU4 and the UK Market Size
11.7.1. Total Market Size of Osteogenesis Imperfecta in EU4 and the UK (2020-2034)
11.7.2. Market Size of Osteogenesis Imperfecta by Therapies in EU4 and the UK (2020-2034)
11.8. Japan Market Size
11.8.1. Total Market Size of Osteogenesis Imperfecta in Japan (2020-2034)
11.8.2. Market Size of Osteogenesis Imperfecta by Therapies
12. KOL Views
13. SWOT Analysis
14.&nbsp;Osteogenesis Imperfecta Unmet Needs
15. Market Access and Reimbursement
15.1. United States
15.1.1. Centre for Medicare and Medicaid Services (CMS)
15.2. EU4 and the UK
15.2.1. Germany
15.2.2. France
15.2.3. Italy
15.2.4. Spain
15.2.5. United Kingdom
15.3. Japan
15.4. MHLW
16. Appendix
16.1. Bibliography
16.2. Report Methodology
17. DelveInsight Capabilities
18. Disclaimer

DelveInsight's “Osteogenesis Imperfecta Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta therapeutics market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Osteogenesis Imperfecta Market

Osteogenesis Imperfecta Market Insight, Epidemiology And Market Forecast - 2034

DelveInsight's Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Osteogenesis Imperfecta, historical